I-European Medicines Agency (EMA) isanda kuvumela ukuphathwa kwezingane ezineminyaka engu-12-17 zomuthi wokugomela i-Covid-19, Moderna. Kuze kube manje, umuthi wokugomela i-Pfizer kuphela onalokhu kugunyazwa.

IModerna, umuthi wokugoma we-mRNA ungumuthi wokugoma wesibili osetshenziswa kakhulu eFrance ngemuva kwe-Pfizer, enabangu-6.368.384 (okuhlanganisiwe komjovo wokuqala nowesibili) abantu abagonywe ngokusho kwe-CovidTracker. Ngakho-ke lesi ngesinye sezizathu ezenza ilabhorethri yaseMelika izimise ekuqaleni kukaJuni ukuze icele ukugunyazwa endaweni yethu. Ngokocwaningo lwakamuva olwenziwe yinkampani yaseMelika ye-biotechnology eshicilelwe ngoMeyi 25, i-serum ephikisana ne-Covid-19 iyaboniswa. "Isebenza kahle kakhulu", okusho ukuthi, ama-93% entsheni eneminyaka eyi-12 kuya kweyi-17. Olubizwa nge-TeenCOVE, ucwaningo lwaselabhorethri lweModerna lubandakanya ababambiqhaza abangaphezu kuka-3 futhi "Akukho ukukhathazeka mayelana nokuphepha kwakhe okuhlonziwe kuze kube manje", icacisa ilabhorethri.

“IKomidi Lemikhiqizo Yemithi Yokusetshenziswa Kwabantu (…) ye-AEM yancoma ukuthi kwandiswe inkomba emuthini wokugomela i-Covid-19 Spikevax (owayewaziwa nge-Covid-19 Vaccine Moderna) ukuze ufake ukusetshenziswa kwawo ezinganeni ezineminyaka eyi-12 kuye kweyi-17 “, kusho umlawuli waseYurophu enkulumweni yabezindaba.

Ngaphansi kokukhuphuka kokuhluka kweDelta, ubhubhane lwe-Covid-19 alukakulungeli ukuyeka. E-Europe ukusabalala kwayo kucishe kube ngama-26%, okuyisibalo okungenzeka sikhuphuke ngokuzayo futhi siphindeke kabili emasontweni amane ezayo. I-United States nayo ikulesi sibalo esiphezulu, ngokusabalala kwe-Covid-19 cishe ngama-60%.